|
|
|
|
| LEADER |
03733nmm a2200289 u 4500 |
| 001 |
EB000634893 |
| 003 |
EBX01000000000000000487975 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9781592594276
|
| 100 |
1 |
|
|a Brown, Dennis M.
|e [editor]
|
| 245 |
0 |
0 |
|a Drug Delivery Systems in Cancer Therapy
|h Elektronische Ressource
|c edited by Dennis M. Brown
|
| 250 |
|
|
|a 1st ed. 2004
|
| 260 |
|
|
|a Totowa, NJ
|b Humana
|c 2004, 2004
|
| 300 |
|
|
|a X, 390 p. 57 illus
|b online resource
|
| 505 |
0 |
|
|a I: Pharmacological Considerations for Drug Delivery Systems in Cancer Medicine -- 1 Systemically Administered Drugs -- 2 Regional Administration of Antineoplastic Drugs -- 3 Theoretical Analyses and Simulations of Anticancer Drug Delivery -- II: Technologies Available for Use in Cancer Drug Delivery Systems -- 4 Biopolymers for Parenteral Drug Delivery in Cancer Treatment -- 5 Hydrogels in Cancer Drug Delivery Systems -- 6 Microparticle Drug Delivery Systems -- 7 Polyethylene Glycol Conjugation of Protein and Small Molecule Drugs: Past, Present, and Future -- 8 Emulsions As Anticancer Delivery Systems -- III: Current Applications: Products Approved or in Advanced Clinical Development -- 9 Liposomal Drug Delivery Systems for Cancer Therapy -- 10 Gliadel®: A New Method for the Treatment of Malignant Brain Tumors -- 11 Intralesional Chemotherapy with Injectable Collagen Gel Formulations -- 12 Sustained-Release Drug Delivery with DepoFoam -- 13 Cancer Vaccines -- IV: Future Directions: Novel Cancer Drug Targets and Delivery Systems -- 14 Gene Therapy of Cancer -- 15 Progress in Antisense Technology -- 16 Tumor Vaccines -- 17 Diagnosis and Treatment of Human Disease Using Telomerase As a Novel Target
|
| 653 |
|
|
|a Pharmacy
|
| 653 |
|
|
|a Cancer
|
| 653 |
|
|
|a Cancer Biology
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 490 |
0 |
|
|a Cancer Drug Discovery and Development
|
| 028 |
5 |
0 |
|a 10.1007/978-1-59259-427-6
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-59259-427-6?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 615.1
|
| 520 |
|
|
|a A major difficulty in successfully treating cancer with drugs is achieving adequate drug concentrations in the diseased areas without overexposing drug-sensitive normal tissues. In a number of cases, specialized drug delivery systems are required to realize a therapeutic gain. In Drug Delivery Systems in Cancer Therapy, Dennis M. Brown has assembled a panel of leading experts to survey all the currently available technologies designed to improve the delivery of today's cancer chemotherapeutic agents. The authors review both the theoretical and practical considerations governing conventional and nonconventional methods of drug administration, and identify promising opportunities for product development. They also profile the use of novel formulation technologies-including synthetic polymers and biomaterials for sustained drug release to achieve greater therapeutic effect-that have demonstrated efficacy in a number of approved and late-stage clinical products. They also consider the benefits of, and future opportunities for, various drug delivery systems, as well as the experimental techniques used in their evaluation. Although the focus is primarily on small molecule delivery, many of the technologies described can also be effective in delivering larger biomolecules. Comprehensive, cutting-edge, and highly practical, Drug Delivery Systems in Cancer Therapy captures for experimental oncologists, medicinal chemists, and pharmacologists the universe of approaches, technologies, and systems available for substantially enhancing the therapeutic outcome of anticancer drug delivery today
|